This statistic shows the top 10 pharmaceutical companies worldwide in 2018, by projected number of originated drugs. For that year, projections said there were 138 such drugs from Swiss-based company Novartis.
- Health & Pharmaceuticals›
- Pharmaceutical Products & Market›
Top pharma companies worldwide by number of originated drugs 2018
Top 10 pharmaceutical companies worldwide by number of originated drugs in 2018*
This statistic shows the top 10 pharmaceutical companies worldwide in 2018, by projected number of originated drugs. For that year, projections said there were 138 such drugs from Swiss-based company Novartis.
Loading statistic...
| Number of originated drugs | |
|---|---|
| Novartis | 138 |
| Pfizer | 126 |
| AstraZeneca | 117 |
| Johnson & Johnson | 116 |
| Roche | 114 |
| GlaxoSmithKline | 111 |
| Merck & Co. | 109 |
| Bristol-Myers Squibb | 96 |
| Takeda | 96 |
| Eli Lilly | 84 |
| Number of originated drugs | |
|---|---|
| Novartis | 138 |
| Pfizer | 126 |
| AstraZeneca | 117 |
| Johnson & Johnson | 116 |
| Roche | 114 |
| GlaxoSmithKline | 111 |
| Merck & Co. | 109 |
| Bristol-Myers Squibb | 96 |
| Takeda | 96 |
| Eli Lilly | 84 |
© Statista 2019
About this statistic
Show source
Download
Settings
Share
Download started
Please be patient - this may take a moment
Please be patient - this may take a moment
Description
Source
More information
This statistic shows the top 10 pharmaceutical companies worldwide in 2018, by projected number of originated drugs. For that year, projections said there were 138 such drugs from Swiss-based company Novartis.
Show more- Show sources information
- Show publisher information
- Release date
- March 2018
- Region
- Worldwide
- Survey time period
- as of January 2017
- Supplementary notes
- * Projected as of January 2018
More information
- Region
- Worldwide
- Survey time period
- as of January 2017
- Supplementary notes
- * Projected as of January 2018
Other interesting statistics
+
+Top 50 pharmaceutical companies - Rx sales and R&D spending 2017
+
+Top 10 biotech and pharmaceutical companies based on market cap 2018
+
+Revenue of Johnson & Johnson worldwide 2011-2018, by segment
+
+Johnson & Johnson's number of employees 2004-2018
+
+2018 list of global top 10 biotech and pharmaceutical companies by employees
+
+Johnson & Johnson's total revenue 2005-2018
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform
You only have access to basic statistics.
Premium Account
Your perfect start with Statista
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$49 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax.
Prices do not include sales tax.
Leading companies trust Statista:
Related Studies: Available to Download in PDF or PPTX Format
All Information
in one Presentation
Johnson & Johnson
- 48 page/s
- English
- pptx
- Detailed references
Everything On "Johnson & Johnson" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.
Statista has been my savior on several occasions. The site is easy to maneuver and the data is in a format that can go right into a report or presentation.Marlene Greenfield
Vice President, Hearst Magazines
Statistics on "Johnson & Johnson"
- Global positioning
The most important statistics
- Top 50 global pharmaceutical companies by prescription sales and R&D spending in 2017 (in billion U.S. dollars)Top 50 pharmaceutical companies - Rx sales and R&D spending 2017
- Top 10 biotech and pharmaceutical companies worldwide based on market capitalization as of 2018 (in billion U.S. dollars)Top 10 biotech and pharmaceutical companies based on market cap 2018
- 2018 ranking of the global top 10 biotech and pharmaceutical companies based on employee number (in 1,000)2018 list of global top 10 biotech and pharmaceutical companies by employees
- Top 10 pharmaceutical companies worldwide by size of R&D pipeline in 2018*Top pharma companies worldwide 2018, by size of R&D pipeline
- Top 10 pharmaceutical companies worldwide by number of originated drugs in 2018*Top pharma companies worldwide by number of originated drugs 2018
- Revenue and income
The most important statistics
- Johnson & Johnson's total revenue from 2005 to 2018 (in million U.S. dollars)Johnson & Johnson's total revenue 2005-2018
- Revenue of Johnson & Johnson worldwide from 2011 to 2018, by segment (in million U.S. dollars)Revenue of Johnson & Johnson worldwide 2011-2018, by segment
- Johnson & Johnson's revenue from 2006 to 2018, by region (in million U.S. dollars)Revenue of Johnson & Johnson 2006-2018 by region
- Johnson & Johnson's net income from 2005 to 2018 (in million U.S. dollars)Johnson & Johnson's net income 2005-2018
- Segments
The most important statistics
- Revenue of Johnson & Johnson's top pharmaceutical products from 2014 to 2018 (in million U.S. dollars)Revenue of Johnson & Johnson's pharmaceutical products 2014-2018
- Revenue of Johnson & Johnson's medical devices and diagnostics segment from 2016 to 2018, by franchise (in million U.S. dollars)Revenue of Johnson & Johnson's medical devices and diagnostics by franchise 2016-2018
- Revenue of Johnson & Johnson's consumer healthcare segment from 2014 to 2018, by franchise (in million U.S. dollars)Revenue of Johnson & Johnson's consumer healthcare segment by franchise 2014-2018
- Miscellaneous
The most important statistics
- Johnson & Johnson's expenditure on research and development from 2005 to 2018 (in million U.S. dollars)Johnson & Johnson's expenditure on research and development 2005-2018
- Johnson & Johnson's research and development expenditure as a percent of revenue from 2005 to 2018Johnson & Johnson's R&D expenditure as a percent of revenue 2005-2018
- Johnson & Johnson's number of employees from 2004 to 2018 (in 1,000)Johnson & Johnson's number of employees 2004-2018
- Brand value of Johnson & Johnson's cosmetic brands worldwide from 2011 to 2013 (in million U.S. dollars)Brand value of Johnson & Johnson's cosmetic brands worldwide 2011-2013
- Forecasts
The most important statistics
- Revenue of Johnson & Johnson's pharmaceuticals segment worldwide from 2012 to 2024, by product category* (in billion U.S. dollars)Revenue of Johnson & Johnson's pharmaceuticals segment worldwide 2012-2024
- Johnson & Johnson's market share of the over-the-counter and nutritionals market worldwide from 2013 to 2021*Johnson & Johnson's market share of the global OTC and nutritionals market
- Forecast of EBITDA of Johnson & Johnson for 2018 to 2020 (in million U.S. dollars)Forecast of EBITDA of Johnson & Johnson 2018-2020
Popular Related Keywords
- drugs
- origin
- Pharmaceutical companies
- Show more
- pharmaceutical
- drug manufacturers
- research
- drug
- health costs
- R&D
- number
- healthcare
- health expenditure
- research and development
- registered
- phase
- development phases
- pipeline
- pharmaceutical expenditure
- clinical trials
- research and innovation
- health sector
- product pipelines
- research areas
- pharmaceutical manufacturers
- health market
- top
- unregistered
- biopharmaceutical
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Top pharma companies worldwide 2018, by size of R&D pipeline
- Pharma companies worldwide with active R&D pipelines 2001-2018
- Distribution of pharmaceutical R&D companies by region 2018
- U.S. number of venture capital deals for neurology companies 2006-2017
- Worldwide top origins for pipeline drugs by number of active drugs 2018
- Worldwide pipeline drugs by delivery route share 2018
- Multiple sclerosis management products in development in the U.S. 2014
- Trust in pharmaceutical companies worldwide by clinical trial knowledge 2017
- U.S. psychiatry company IPO financing 2006-2017
- U.S. venture investments in infectious disease companies from 2006 to 2017
- U.S. infectious disease company IPOs 2006-2017
- U.S. number of venture capital deals for infectious disease companies 2006-2017
- U.S. number of IPOs for neurology companies 2006-2017
- U.S. venture funding of therapeutic companies by disease type 2017
- Top approved MS therapies in the U.S. by ARR 2014
- Growth of top pharmaceutical companies in South Africa in 2014-2015
- Value of top worldwide pharmaceutical company acquisitions 1994-2014
- U.S. Pharmaceuticals: spending on research and development 1980-2017
Studies
- Pharmaceutical trends in Europe
- Indicatori Farmaceutici
- Pharmaceutical industry in Italy
- Pharmaceutical industry in China
- Pharmaceutical industry in Japan
- Pharmaceutical industry in the Netherlands
- Trends in Retail Prices of Prescription Drugs Widely Used by Older Americans, 2006 to 2013
- The 2018 Genentech Oncology Trend Report
- PAGB Annual Review 2017-2018
- Generic Pharmaceutical Industry Yearbook 2016
- Great Expectations: Why Pharma Companies Can’t Ignore Patient Services
- Antibiotic use in the United Kingdom (UK)
- Biotechnology in Germany
- 2018 PhRMA Annual Membership Survey
- The 2017 Genentech Oncology Trend Report
Statistics on the topic
Free statistics
- Top 10 pharmaceutical companies worldwide by size of R&D pipeline in 2018*
- Top 10 pharmaceutical companies worldwide by number of originated drugs in 2018*
- Johnson & Johnson's net income from 2005 to 2018 (in million U.S. dollars)
- Johnson & Johnson's expenditure on research and development from 2005 to 2018 (in million U.S. dollars)
- Revenue of Johnson & Johnson's pharmaceuticals segment worldwide from 2012 to 2024, by product category* (in billion U.S. dollars)
- Johnson & Johnson's market share of the over-the-counter and nutritionals market worldwide from 2013 to 2021*
- Total number of pharmaceutical companies with active R&D pipelines worldwide from 2001 to 2018
- Top 10 origins of drugs in R&D pipeline worldwide by number of active drugs in 2018*
- Percentage of drugs in R&D pipeline worldwide by delivery route in 2018*
- Number of multiple sclerosis drugs in development in the United States as of July 2014
- Venture investments in infectious disease companies in the U.S. from 2006 to 2017 (in million U.S. dollars)
- Growth of top 10 pharmaceutical companies in South Africa in 2014-2015*
Premium Statistics
- Top 50 global pharmaceutical companies by prescription sales and R&D spending in 2017 (in billion U.S. dollars)
- Top 10 biotech and pharmaceutical companies worldwide based on market capitalization as of 2018 (in billion U.S. dollars)
- 2018 ranking of the global top 10 biotech and pharmaceutical companies based on employee number (in 1,000)
- Johnson & Johnson's total revenue from 2005 to 2018 (in million U.S. dollars)
- Revenue of Johnson & Johnson worldwide from 2011 to 2018, by segment (in million U.S. dollars)
- Johnson & Johnson's revenue from 2006 to 2018, by region (in million U.S. dollars)
- Revenue of Johnson & Johnson's top pharmaceutical products from 2014 to 2018 (in million U.S. dollars)
- Revenue of Johnson & Johnson's medical devices and diagnostics segment from 2016 to 2018, by franchise (in million U.S. dollars)
- Revenue of Johnson & Johnson's consumer healthcare segment from 2014 to 2018, by franchise (in million U.S. dollars)
- Johnson & Johnson's research and development expenditure as a percent of revenue from 2005 to 2018
- Johnson & Johnson's number of employees from 2004 to 2018 (in 1,000)
- Brand value of Johnson & Johnson's cosmetic brands worldwide from 2011 to 2013 (in million U.S. dollars)
- Forecast of EBITDA of Johnson & Johnson for 2018 to 2020 (in million U.S. dollars)
- Distribution of pharmaceutical R&D companies worldwide by country as of 2018*
- Number of venture capital deals for neurology companies in the U.S. from 2006 to 2017
- Percentage of adults that trust pharmaceutical companies to release accurate information about new medicines as of 2017, by clinical trial knowledge
- Amount raised through initial public offerings (IPOs) from psychiatry companies in the U.S. from 2006 to 2017 (in million U.S. dollars)*
- Number of initial public offerings (IPOs) from companies in infectious disease in the U.S. from 2006 to 2017*
- Number of venture capital deals for infectious disease companies in the U.S. from 2006 to 2017
- Number of initial public offerings (IPOs) for neurology companies in the U.S. from 2006 to 2017*
- Venture funding of U.S. therapeutic companies in 2017, by disease type (in million U.S. dollars)
- Selected approved multiple sclerosis therapies as of 2014, ranked by ARR*
- Value of acquisitions made by top pharmaceutical companies between 1994 and 2014 (in billion U.S. dollars)
- Pharmaceutical research and development expenditure in the U.S. from 1980 to 2017 (in billion U.S. dollars)
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Topics
About Statista
Statista offers dossiers and reports on over 170 industries. With Statista you are always able to make informed decisions and boost your work efficiency.
Internet & Telecommunications
- Social Media
- E-Commerce
- Online Video & Entertainment
- Advertising & Marketing
Consumer Goods & FMCG
- Alcoholic Beverages
- Cleaning Products
- Cosmetics & Personal Care
- Food & Nutrition
Retail & Trade
- Health & Hygiene
- International Trade
- Shopping Behavior
- Sports & Leisure
Travel, Tourism & Hospitality
- Business Travel
- Leisure Travel
- Accomodation
- Restaurants
Society
- Demographics
- Economy
- Education & Science
- Politics & Government
Transportation & Logistics
- Aviation
- Rail Transport
- Vehicles & Road Traffic
- Water Transport
Please log in to access our additional functions
Register in seconds and access exclusive features.
Basic Account |
Instant Access
Premium Account | ||
|---|---|---|---|
Our servicesClick the question mark for further information | Free |
$49 per month* | |
| Basic statistics | |||
| Premium statistics | |||
|
Graph download
| |||
| Download PDF | |||
|
Excel download
| |||
| Register | Purchase now | ||
*Duration: 12 months, billed annually, single license
Yes, let me download!
...and make my research life easier.
Exclusive Corporate feature
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Corporate Account
News
News
Latest News
Updated
The Italian pharmaceutical market
The Italian pharmaceutical market is among the fastest growing ones worldwide. This dossier provides data on the trends of the market, with special focus on pharmaceutical segments.
Updated
Update & expansion: Country Reports
To our 150 Reports we added:
- Global Consumer Survey content
- Operational risk index by Fitch
- And more …
New
New Dossier: Plastic industry worldwide
The global plastics industry is growing by approximately three percent every year. This dossier provides information about the global plastics industry in general as well as chapters on the major types of plastic, and recycling rates.
Updated
New Digital Market Outlook Reports for 2019
Updates on eCommerce, Digital Media, eTravel, eServices and more
- Market figures for 2018 to 2023
- Company and startup profiles
- User demographics
New
New Dossier: United States coal mining industry
U.S. coal production has steadily declined in the past decade, but has been in the news in recent years due to President Trump's desire to revitalize the industry. This document provides an overview of the key figures, leading companies, and the employment trends in the U.S. coal mining industry.
New
Global Consumer Survey offers PowerPoint export
This new export feature offers
- Structured graphical representation of the data
- Tailored target group analysis
- Option for further processing
New
New Dossier: E-commerce in Poland
The Polish e-commerce market is one of the fastest developing e-commerce markets in Europe. The latest data for Poland is presented in this dossier.
New
New Dossier: Plastic waste in the U.S.
Plastic waste is an issue of global concern. Since China banned the import of recycled plastic, the U.S. has had to make adjustments to its management of plastic waste. This dossier provides an overview of plastic waste in the U.S.
New
New Dossier: Hedge funds
This dossier provides an overview of hedge funds worldwide. Global hedge fund assets, performance, investors, and other topics are highlighted.
New
New exclusive OOH advertising data by OAAA
The Outdoor Advertising Association of America covers amongst others
- Number of billboards
- Outdoor advertising revenue
- Number of out-of-home displays
New
What happens after a no-deal Brexit?
Find data, perceptions & more about
- Economic consequences
- Impact on the labor market
- A second referendum
New
ecommerceDB.com: Ranking update – Spain
Understand the recent developments in the Spanish eCommerce market!
- URL-related revenues
- Relevant online store KPIs
- eCommerce-related contacts
New
Insights into the European banking sector
- Extended statistical dossier
- Insights, explanations & interpretations
- Challenges of the digital future
New
Dossier: Latin American online shopping events
eCommerce is rapidly becoming a part of the Latin American shopping culture. The dossier includes data on
- Regional online shopping events
- Events by country
Updated
Updated Brexit analysis in UK Industry Reports
The outline of potential impacts of Brexit on UK industries has been updated in the UK Industry Reports.
New
New Dossier: Digital Marketing in Italy
Italian enterprises invest significantly in digital marketing. Find out about
- Relevant aspects & KPIs
- New trends
- Different strategies
New
What is football all about, anyway?
Statista European Football Benchmark
- The big 5 European leagues
- All about the clubs & fans
- Sponsors & how they fit in
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.